Download our Perspective

Cerapedics’ CEO Valeska Schroeder discusses the company’s newly PMA-approved PearlMatrix P-15 Peptide Enhanced Bone Graft and its unique advantages over existing bone graft options in an interview with SmartTRAK. To learn more, read our article!